Christopher Rex

Inga fler pågående positioner

50 år

Consumer Services

Health Technology

Finance

Profil

Christopher Rex is the founder of Afraxis, Inc., a company founded in 2007.
He held the title of Chief Scientific Officer from 2013 to 2021.
Dr. Rex also worked as a Program Director at T123 LLC from 2018 to 2021.
He obtained a doctorate degree from the University of California, Irvine in 2008 and an undergraduate degree from the University of California, Santa Barbara in 2002.

Tidigare kända positioner av Christopher Rex

Företag	Position	Slut
Afraxis, Inc. Afraxis, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of fragile X syndrome and autism	Grundare	2021-09-01
T123 LLC T123 LLC Investment ManagersFinance T123 invests in companies located in the United States. The firm targets companies operating in the field of drug development industry. It provides financing for early stage capital requirements.	Direktör/Styrelseledamot	2021-04-01

Se detaljerna i Christopher Rexs erfarenhet

Christopher Rexs utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Christopher Rexs erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	4
Afraxis, Inc. Afraxis, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of fragile X syndrome and autism	Health Technology
University of California, Irvine University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of California, Santa Barbara University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
T123 LLC T123 LLC Investment ManagersFinance T123 invests in companies located in the United States. The firm targets companies operating in the field of drug development industry. It provides financing for early stage capital requirements.	Finance